Archive | Between Sessions Brief

All Briefs

Psychedelics Research, Chatbot Gaps, and Documentation Bias

Apr 28, 2026

This week brought a federal push on psychedelic research, an investigation into AI chatbots and HIPAA blind spots, and a clinical study on how documentation language tracks with diagnosis. We also cover workforce shortage numbers, new pediatric psychiatric capacity in Maryland and a new APA tool for evaluating mental health apps.

Brain Scans, Billing AI, and Value-Based Care

Apr 21, 2026

A new APA survey reveals where psychiatrists stand on AI, and a CMS model quietly reshaping how behavioral health gets paid is gaining early momentum. We also cover an insurer billing pattern that makes precise documentation more important than ever, a meaningful study on therapist wellbeing and early dropout, and new findings on depression subtypes that may eventually change how medication decisions get made.

GLP-1s and Addiction, Tennessee's AI Law, and Alma's AI Layoffs

Apr 14, 2026

A large WashU study links GLP-1 medications to lower rates of substance use disorders, and Tennessee just became the first state to give clients legal standing against AI tools marketed as therapy. We also cover Alma's AI-driven layoffs, single-session therapy's growing reach, and a psychiatrist's pointed critique of the second victim framework.